Skip to main content
. 2018 Apr 18;2018(4):CD006545. doi: 10.1002/14651858.CD006545.pub3

Pandey 2010.

Methods Parallel RCT
Participants Fewer than 2 superficial haemangiomas less than 5 cm
Age: unclear
Sex: unclear
Country: unclear
Interventions Topical steroid (mometasone furoate) given twice daily versus intralesional steroid (triamcinolone acetonide), injected at monthly intervals using 24‐gauge needle at doses of 1 to 2 mg/kg
Outcomes Primary outcome:
  • Excellent response


Secondary outcome:
  • Good response


Complications (including irritation, hypopigmentation, pain, bleeding, infection, cutaneous atrophy, Cushingoid facies, and growth retardation)
Notes  

GLUT1: glucose transporter 1; MRI: magnetic resonance imaging; PHACE syndrome: posterior fossa malformations–haemangiomas–arterial anomalies–cardiac defects–eye abnormalities syndrome; PICC line: peripherally inserted central catheter; RCT: randomised controlled trial; RIH: refractory infantile haemangiomas.